Austria FWF · Open · Consortium required

European Partnership ERA4Health

Official call page ↗

In brief, in English

This call funds transnational collaborative clinical studies addressing cardiovascular, autoimmune, metabolic, and non-communicable respiratory diseases. Researchers in biomedical research at universities, non-academic research institutions, and research departments can apply as part of a multinational consortium.

Written by a model from the publisher's text. The official page is the authority. How data is produced

Transnational collaborative research for health and well-being Submissions: Nov. 16, 2026 to Jan. 14, 2027 (12:00 pm Vienna local time) The European Partnership Fostering a European Research Area for Health (ERA4Health) aims to flexibly and effectively coordinate funding activities in the field of health and greater well-being in the European Research Area. The partnership supports transnational collaborative research in Europe through joint strategic planning to address priority fields of public health in Europe. The ninth call, “Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations – IICS4all 2027,” will be open until January 14, 2027 for pre-proposals and June 14, 2027 for full proposals. Target group The funding program is aimed at researchers working in the field of biomedical research at universities, non-academic research institutions, and research departments in related sectors. Funding goals The ERA4Health European Partnership has several objectives: Expanding biomedical and public health research, including clinical and intervention areas, generating new knowledge to improve the use of existing health technologies in practice, and building further capacity in medicine and clinical trials at the European level. The ultimate goal is to facilitate research projects and innovations that will improve both the health of the European population as well as healthcare delivery. Funding period and funding amount The following applies for FWF-funded principal investigators: The funding period is at least 24 months and up to 48 months; the minimum funding amount is €200,000, and the maximum funding amount is €450,000. Requirements The requirements and specifications for the FWF programs Principal Investigator Projects or Clinical Research apply. Information on the current call “Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations – IICS4all 2027Multi-country Investigator Initiated Clinical Trials in Cardiovascular, Autoimmune and Metabolic Diseases (Trials4Health)” The aim of the call is to support randomized, interventional, and pragmatic comparative-effectiveness clinical studies and/or studies on the repurposing of approved drugs, that are designed as randomized interventional trials.  The interventions must be of high public relevance in one or more of the following fields:  Cardiovascular diseases Autoimmune disorders Metabolic disorders Non-communicable respiratory diseases For further information on thematic requirements and restrictions of this call, please see the ERA4Health website. Each proposal must involve a minimum of three and a maximum of five partners from at least two different participating partner countries. A joint proposal must be submitted by the project coordinator to the central Call Secretariat. The researchers are funded by their respective national/regional funding organization. The call is being co-financed by the European Union.  The current list of participating countries can be found on the ERA4Health website. Approval Decided by the Scientific Board based on a recommendation of the Call Secretariat. Application information Applications must be submitted to both the Call Secretariat and the FWF. This applies to both the pre-proposal and the full proposal. Submission to the Call Office Please see the ERA4Health website for the link to the Call Secretariat’s application system. Application and review are carried out in a two-stage procedure. Submission of pre-proposals: November 16, 2026 to January 14, 2027 (12:00 noon CET) Deadline for full proposals: May 1, 2027 to June 14, 2027 (12:00 noon CEST) Funding decision: expected in November 2027 Submission to the FWF The application guidelines for the FWF program Principal Investigator Projects or Clinical Research apply for this call; the amended versions wil

Change history

First seen 17 Nov 2026, last checked 22 Nov 2026. 1 recorded version.

  • 17 Nov 2026 · 88070bf97f90

Report a problem with this record · How data is produced